Combination CBD/THC in the management of chemotherapy-induced peripheral neuropathy: a randomized double blind controlled trial

IntroductionChemotherapy-induced peripheral neuropathy (CIPN) can greatly impair function, leading to disability or truncated treatment in cancer patients. Previous animal studies show that cannabidiol (CBD) and delta-9- tetrahydrocannabinol (THC) can ameliorate CIPN. This study assessed the effect...

全面介紹

書目詳細資料

Principais autores:	Marisa Weiss, Muath Giaddui, Stephanie Kjelstrom, Joseph Gary, Sara Jane Ward, Jessica Burrell, Katherine Diguilio, Gabrielle Bidas, Ebuwa Erebor, Sam Meske, Lisa Saeed, Sarah Windawi, Katherine Aliano Ruiz, Arezoo Ghaneie, Julianne Hibbs, John Marks, David Holtz, Zonera Ali, Aarthi Shevade, Jennifer Sabol, Robin Ciocca, Eric Zeger, Paul Gilman, Sharon Larson, Shoichi Shimamoto, Diana Martinez
格式:	Artigo
語言:	Inglês
出版:	Frontiers Media S.A. 2025-10-01
叢編:	Frontiers in Oncology
主題:	chemotherapy-induced peripheral neuropathy cannabinoids cannabidiol (CBD) delta-9-tetrahydrocannabinol (THC) sensory impairment cancer
在線閱讀:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1590168/full
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!